PD-L1 checkpoint inhibitor gene therapy (Affimer/gtGTU vector) (Avacta/FIT Biotech)
N/A
Report date: 2025/02/01 20:00:06
Base Information
Drug NamePD-L1 checkpoint inhibitor gene therapy (Affimer/gtGTU vector) (Avacta/FIT Biotech)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[1] N/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAvacta Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesAvacta LtdFIT Biotech Oyj Plc
Active IndicationsN/A
Inactive Indications +[1] N/A
Other Information
ATC CodeN/A
Related LinksN/A